Evidence map›Paper›PMID 40198850›Full record

ReviewAnnual review of virology2025

APOBEC3G Antagonism by Vif, or When Structure Meets Biological and Evolutionary Studies.

Yen-Li Li, Caroline A Langley, Michael Emerman, John D Gross

Abstract readReview
In one paragraph

Review in Annual review of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yen-Li LiInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Caroline A LangleyDivisions of Human Biology and Basic Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Michael EmermanDivisions of Human Biology and Basic Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
John D GrossDepartment of Pharmaceutical Chemistry and Quantitative Bioscience Institute, University of California, San Francisco, California, USA; email: jdgross@cgl.ucsf.edu.

Funding

Project 3U54AI170792 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Nevan J Krogan · 2022 to 2026
$35.7M
X-ray Screening and Rapid Structure DeterminationP50AI150476 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EMERMAN, MICHAEL · 2019 to 2021
$14.4M
NIAID NIH HHS P50 AI150476NIAID NIH HHS U54 AI170792
6 · The paper itself

Abstract

Restriction factors serve as innate host defenses against viruses and act as critical barriers to cross-species transmission. In response, viruses have evolved accessory proteins to counteract restriction factors, enabling evasion of innate immune responses. The interplay between primate APOBEC3G (A3G) and lentiviral virion infectivity factor (Vif) exemplifies a molecular arms race between a restriction factor and its viral antagonist. This review integrates evolutionary and functional analyses of this system, showing how genetic signatures of molecular arms races map onto high-resolution cryo-electron microscopy structures. However, A3G's interaction with Vif is not limited to the evolutionary dynamic interface, characterized by rapidly evolving residues under selective pressure, but also involves a conserved interface mediated by RNA binding that positions A3G for antagonism by Vif. These findings propose a model wherein Vif and potentially other viral antagonists target functional complexes using a dual strategy: leveraging both adaptive interfaces subject to evolutionary pressures and conserved interfaces that constrain host escape mechanisms.

Indexed as

APOBEC-3G DeaminaseHIV-1vif Gene Products, Human Immunodeficiency VirusAnimalsCryoelectron MicroscopyEvolution, MolecularHost-Pathogen InteractionsHumansImmune EvasionImmunity, InnateProtein BindingAPOBEC-3G DeaminaseAPOBEC3G protein, humanvif Gene Products, Human Immunodeficiency VirusAPOBEC3GHIV-1lentivirusespositive selectionubiquitin-proteasome systemVif

Identifiers

PMID40198850
PMCPMC13016362

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.